D.E. Shaw & Co’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.44M Sell
141,783
-10,405
-7% -$326K ﹤0.01% 1502
2025
Q1
$5.11M Buy
152,188
+65,215
+75% +$2.19M ﹤0.01% 1334
2024
Q4
$3.41M Sell
86,973
-117,919
-58% -$4.62M ﹤0.01% 1515
2024
Q3
$8.07M Buy
204,892
+43,170
+27% +$1.7M 0.01% 1050
2024
Q2
$6.31M Sell
161,722
-36,804
-19% -$1.43M 0.01% 1156
2024
Q1
$8.55M Buy
198,526
+114,373
+136% +$4.92M 0.01% 993
2023
Q4
$3.88M Buy
84,153
+43,606
+108% +$2.01M ﹤0.01% 1358
2023
Q3
$1.39M Sell
40,547
-58,198
-59% -$1.99M ﹤0.01% 1895
2023
Q2
$3.8M Sell
98,745
-107,927
-52% -$4.16M ﹤0.01% 1399
2023
Q1
$7.4M Sell
206,672
-153,749
-43% -$5.5M 0.01% 1115
2022
Q4
$14.2M Sell
360,421
-49,142
-12% -$1.94M 0.02% 763
2022
Q3
$14.8M Buy
409,563
+83,021
+25% +$3M 0.02% 703
2022
Q2
$9.93M Sell
326,542
-3,985
-1% -$121K 0.01% 986
2022
Q1
$10.1M Sell
330,527
-144,613
-30% -$4.42M 0.01% 1091
2021
Q4
$14.8M Buy
475,140
+326,261
+219% +$10.2M 0.01% 870
2021
Q3
$2.28M Sell
148,879
-15,192
-9% -$232K ﹤0.01% 2018
2021
Q2
$3.06M Sell
164,071
-10,924
-6% -$203K ﹤0.01% 1760
2021
Q1
$3.13M Sell
174,995
-8,745
-5% -$157K ﹤0.01% 1591
2020
Q4
$2.83M Sell
183,740
-8,573
-4% -$132K ﹤0.01% 1590
2020
Q3
$2.13M Sell
192,313
-17,305
-8% -$192K ﹤0.01% 1601
2020
Q2
$2.63M Buy
209,618
+67,110
+47% +$842K ﹤0.01% 1471
2020
Q1
$1.62M Buy
142,508
+95,631
+204% +$1.08M ﹤0.01% 1622
2019
Q4
$615K Buy
46,877
+15,979
+52% +$210K ﹤0.01% 2105
2019
Q3
$278K Buy
30,898
+132
+0.4% +$1.19K ﹤0.01% 2305
2019
Q2
$303K Sell
30,766
-24,866
-45% -$245K ﹤0.01% 2302
2019
Q1
$565K Sell
55,632
-75,588
-58% -$768K ﹤0.01% 2076
2018
Q4
$828K Buy
+131,220
New +$828K ﹤0.01% 1918